| The type I interferon signaling pathway is a target for glucocorticoid inhibition. | |
| | |
MedLine Citation:
|
PMID: 20679482 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Type I interferon (IFN) is essential for host defenses against viruses; however, dysregulated IFN signaling is causally linked to autoimmunity, particularly systemic lupus erythematosus. Autoimmune disease treatments rely on glucocorticoids (GCs), which act via the GC receptor (GR) to repress proinflammatory cytokine gene transcription. Conversely, cytokine signaling through cognate Jak/STAT pathways is reportedly unaffected or even stimulated by GR. Unexpectedly, we found that GR dramatically inhibited IFN-stimulated gene (ISG) expression in macrophages. The target of inhibition, the heterotrimeric STAT1-STAT2-IRF9 (ISGF3) transcription complex, utilized the GR cofactor GRIP1/TIF2 as a coactivator. Consequently, GRIP1 knockdown, genetic ablation, or depletion by GC-activated GR attenuated ISGF3 promoter occupancy, preinitiation complex assembly, and ISG expression. Furthermore, this regulatory loop was restricted to cell types such as macrophages expressing the GRIP1 protein at extremely low levels, and pharmacological disruption of the GR-GRIP1 interaction or transient introduction of GRIP1 restored RNA polymerase recruitment to target ISGs and the subsequent IFN response. Thus, type I IFN is a cytokine uniquely controlled by GR at the levels of not only production but also signaling through antagonism with the ISGF3 effector function, revealing a novel facet of the immunosuppressive properties of GCs. |
| | |
Authors:
|
Jamie R Flammer; Jana Dobrovolna; Megan A Kennedy; Yurii Chinenov; Christopher K Glass; Lionel B Ivashkiv; Inez Rogatsky |
Publication Detail:
|
Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't Date: 2010-08-02 |
Journal Detail:
|
Title: Molecular and cellular biology Volume: 30 ISSN: 1098-5549 ISO Abbreviation: Mol. Cell. Biol. Publication Date: 2010 Oct |
Date Detail:
|
Created Date: 2010-09-10 Completed Date: 2010-11-15 Revised Date: 2012-05-10 |
Medline Journal Info:
|
Nlm Unique ID: 8109087 Medline TA: Mol Cell Biol Country: United States |
Other Details:
|
Languages: eng Pagination: 4564-74 Citation Subset: IM |
Affiliation:
|
Graduate Program in Immunology and Microbial Pathogenesis, Weill Cornell Graduate School of Medical Sciences, 1300 York Avenue, New York, New York 10021, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
3T3 Cells Adaptor Proteins, Signal Transducing / genetics, metabolism* Animals Blotting, Western Cell Line Cells, Cultured Dexamethasone / pharmacology Fibroblasts / cytology, drug effects, metabolism Gene Expression / drug effects* Glucocorticoids / pharmacology* Interferon Type I / pharmacology* Interferon-Stimulated Gene Factor 3, alpha Subunit / genetics, metabolism Macrophages / cytology, drug effects*, metabolism Mice Mice, Inbred C57BL Nerve Tissue Proteins / genetics, metabolism* Protein Binding / drug effects RNA Interference Reverse Transcriptase Polymerase Chain Reaction Signal Transduction / genetics Transcription, Genetic / drug effects |
| Grant Support | |
ID/Acronym/Agency:
|
R01 AI046712-10/AI/NIAID NIH HHS; R01 AI046712-11/AI/NIAID NIH HHS; R01 AI046712-12/AI/NIAID NIH HHS; R01 AI046712-13/AI/NIAID NIH HHS; R01 AI059636-03/AI/NIAID NIH HHS; R01 AI059636-04/AI/NIAID NIH HHS; R01 AI068820/AI/NIAID NIH HHS; R01 AI068820-05/AI/NIAID NIH HHS; R01 AR050401/AR/NIAMS NIH HHS; R01 AR050401-05/AR/NIAMS NIH HHS; R01 AR050401-06A2/AR/NIAMS NIH HHS; R01 AR050401-07/AR/NIAMS NIH HHS; T32 AR07517/AR/NIAMS NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Adaptor Proteins, Signal Transducing; 0/Glucocorticoids; 0/Grip1 protein, mouse; 0/Interferon Type I; 0/Interferon-Stimulated Gene Factor 3, alpha Subunit; 0/Nerve Tissue Proteins; 50-02-2/Dexamethasone |
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: MeCP2 binds cooperatively to its substrate and competes with histone H1 for chromatin binding sites.
Next Document: Requirement of JIP1-mediated c-Jun N-terminal kinase activation for obesity-induced insulin resistan...